Alfredo R. Galassi 1, MD; Gerald S. Werner 2, MD, PhD; Marouane Boukhris 3, MD; Lorenzo Azzalini 4, MD, PhD; Kambis Mashayekhi 5, MD; Mauro Carlino 4, MD; Alexandre Avran 6, MD, MSc; Nikolaos V. Konstantinidis 7, MD; Luca Grancini 8, MD; Leszek Bryniarski 9, MD, PhD; Roberto Garbo 10, MD; Nenad Bozinovic 11, MD; Anthony H. Gershlick 12, MD; Sudhir Rathore 13, MD; Carlo Di Mario 14, MD, PhD; Yves Louvard 15, MD; Nicolaus Reifart 16, MD, PhD; Georgios Sianos 7, MD, PhD; on behalf of the EuroCTO Club
1. Department of Experimental and Clinical Medicine, University of Catania, Catania, Italy; 2. Medizinische Klinik I (Cardiology & Intensive Care), Klinikum Darmstadt GmbH, Darmstadt, Germany; 3. Department of Cardiology, Abderrahmen Mami Hospital, Ariana - Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia; 4. Interventional Cardiology Division, Cardio-Thoraco-Vascular Department, San Raffaele Scientific Institute, Milan, Italy; 5. Division of Cardiology and Angiology II, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen, Germany; 6. Arnault Tzanck Institute, St Laurent du Var, Nice, France; 7. AHEPA University General Hospital of Thessaloniki, 1st Cardiology Department, Thessaloniki, Greece; 8. Centro Cardiologico Monzino, IRCCS, Milan, Italy; 9. II Department of Cardiology and Cardiovascular Interventions, University Hospital, Jagiellonian University Medical College, Krakow, Poland; 10. Policlinico San Giovanni Bosco, Turin, Italy; 11. Department of Invasive Cardiology and Electrostimulation, Clinic for Cardiovascular Diseases, Clinical Center Nis, Nis, Serbia; 12. Biomedical Research Centre, University of Leicester and University Hospitals of Leicester, Leicester, United Kingdom; 13. Frimley Park Hospital NHS Foundation Trust, Frimley, United Kingdom; 14. Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy; 15. Ramsay Générale de Santé - Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Massy, France; 16. Department of Cardiology, Petrus-Krankenhaus, Wuppertal, Germany
Since its inception in December 2006, the EuroCTO Club has strived to provide the framework for state-of-the-art chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in Europe and nearby regions. Among its initiatives, the EuroCTO Club has published a set of recommendations regarding the technical aspects of CTO PCI, whose last edition dates to 2012. The EuroCTO Club consensus document discusses CTO PCI clinical indications, techniques and equipment use, as well as the qualifications of operators/centres. Given the considerable amount of progress made by this subspecialty in recent years, there is a need for an updated document that includes data from recent clinical trials and registries, information on novel devices and techniques, and an up-to-date revision on the training requirements to approach CTO PCI. The current updated consensus document of the EuroCTO Club reflects the expertise of European operators to promote the widespread application of state-of-the-art CTO PCI, not only in Europe but also across neighbouring communities.
No account yet? Create my pcr account
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
chronic total occlusiondrug-eluting stentstable angina
Coronary interventionsStable CADCTO
Read next article
Is it time to abandon drug-eluting stents for saphenous venous graft percutaneous coronary intervention?